Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
46.36 USD | -1.80% |
|
+1.22% | +21.74% |
11/07 | Freeport-McMoRan Medium-Term Outlook Constructive Amid Softer Copper Demand, UBS Says | MT |
11/07 | CICC Adjusts Freeport-McMoRan's PT to $51.60 From $44, Keeps Outperform Rating | MT |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.52 | 11.5 | 8.9 | 7.46 | 8.08 | |||||
Return on Total Capital | 5.2 | 16.88 | 12.85 | 10.59 | 11.46 | |||||
Return On Equity % | 4.79 | 25.74 | 18.71 | 14.38 | 15.69 | |||||
Return on Common Equity | 6.12 | 35.6 | 23.44 | 11.42 | 10.99 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 30.1 | 47.33 | 42.63 | 40.38 | 39.55 | |||||
SG&A Margin | 2.64 | 1.65 | 1.95 | 2.28 | 2.09 | |||||
EBITDA Margin % | 28.61 | 45.99 | 40.9 | 37.01 | 37.46 | |||||
EBITA Margin % | 18.07 | 37.25 | 32.04 | 27.67 | 28.39 | |||||
EBIT Margin % | 16.43 | 36.3 | 30.97 | 27.06 | 27.27 | |||||
Income From Continuing Operations Margin % | 6.09 | 23.48 | 19.66 | 16.41 | 17.28 | |||||
Net Income Margin % | 4.22 | 18.85 | 15.22 | 8.09 | 7.42 | |||||
Net Avail. For Common Margin % | 4.2 | 18.82 | 15.19 | 8.06 | 7.4 | |||||
Normalized Net Income Margin | 6.32 | 16.8 | 13.91 | 8.11 | 7.31 | |||||
Levered Free Cash Flow Margin | 9.91 | 26.49 | 8.93 | -4.56 | 9.27 | |||||
Unlevered Free Cash Flow Margin | 12.39 | 28.02 | 10.45 | -3.15 | 10.06 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.34 | 0.51 | 0.46 | 0.44 | 0.47 | |||||
Fixed Assets Turnover | 0.48 | 0.76 | 0.72 | 0.67 | 0.69 | |||||
Receivables Turnover (Average Receivables) | 17.39 | 22.18 | 18.19 | 17.96 | 28.49 | |||||
Inventory Turnover (Average Inventory) | 2.49 | 2.87 | 2.7 | 2.42 | 2.39 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.72 | 2.52 | 2.46 | 2.42 | 2.42 | |||||
Quick Ratio | 1.48 | 1.66 | 1.57 | 1.1 | 0.92 | |||||
Operating Cash Flow to Current Liabilities | 0.88 | 1.31 | 0.81 | 0.91 | 1.3 | |||||
Days Sales Outstanding (Average Receivables) | 21.05 | 16.46 | 20.06 | 20.32 | 12.85 | |||||
Days Outstanding Inventory (Average Inventory) | 146.88 | 127.26 | 135.12 | 150.53 | 153.03 | |||||
Average Days Payable Outstanding | 58.72 | 50.67 | 62.85 | 65 | 59.6 | |||||
Cash Conversion Cycle (Average Days) | 109.21 | 93.05 | 92.34 | 105.85 | 106.28 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 53.24 | 42.44 | 44.04 | 36.08 | 33.84 | |||||
Total Debt / Total Capital | 34.74 | 29.79 | 30.57 | 26.51 | 25.28 | |||||
LT Debt/Equity | 52.86 | 40.66 | 39.71 | 32.97 | 33.36 | |||||
Long-Term Debt / Total Capital | 34.49 | 28.54 | 27.57 | 24.23 | 24.92 | |||||
Total Liabilities / Total Assets | 55.7 | 52.07 | 51.32 | 47.99 | 47.53 | |||||
EBIT / Interest Expense | 4.14 | 14.84 | 12.71 | 12.01 | 21.76 | |||||
EBITDA / Interest Expense | 7.42 | 18.98 | 17.02 | 16.76 | 30.49 | |||||
(EBITDA - Capex) / Interest Expense | 3.94 | 15.2 | 10.77 | 7.39 | 15.42 | |||||
Total Debt / EBITDA | 2.38 | 0.92 | 1.16 | 1.14 | 1 | |||||
Net Debt / EBITDA | 1.5 | 0.16 | 0.3 | 0.59 | 0.6 | |||||
Total Debt / (EBITDA - Capex) | 4.48 | 1.15 | 1.83 | 2.59 | 1.98 | |||||
Net Debt / (EBITDA - Capex) | 2.83 | 0.2 | 0.47 | 1.34 | 1.18 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -1.42 | 60.9 | -0.28 | 0.33 | 11.38 | |||||
Gross Profit, 1 Yr. Growth % | 58.55 | 165.61 | -10.96 | -4.96 | 8.31 | |||||
EBITDA, 1 Yr. Growth % | 79.81 | 176.21 | -12.09 | -9.23 | 11.89 | |||||
EBITA, 1 Yr. Growth % | 202.95 | 268.67 | -15.14 | -13.37 | 13.12 | |||||
EBIT, 1 Yr. Growth % | 272.09 | 299.66 | -15.86 | -12.35 | 11.07 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -550.52 | 520.23 | -16.51 | -16.25 | 17.28 | |||||
Net Income, 1 Yr. Growth % | -350.63 | 618.86 | -19.46 | -46.71 | 2.22 | |||||
Normalized Net Income, 1 Yr. Growth % | 1.1T | 421.1 | -18.68 | -41.48 | -5.83 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -341.18 | 607.32 | -17.59 | -46.44 | 1.56 | |||||
Accounts Receivable, 1 Yr. Growth % | 20.38 | 30.94 | 14.38 | -9.51 | -52.19 | |||||
Inventory, 1 Yr. Growth % | -4.42 | 15.52 | 15.19 | 16.99 | 12.34 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 0.79 | 1.77 | 7.52 | 8.18 | 9.12 | |||||
Total Assets, 1 Yr. Growth % | 3.27 | 13.95 | 6.39 | 2.77 | 4.46 | |||||
Tangible Book Value, 1 Yr. Growth % | 9.86 | 38.83 | 11.58 | 7.48 | 5.42 | |||||
Common Equity, 1 Yr. Growth % | 9.42 | 37.41 | 11.27 | 7.32 | 5.32 | |||||
Cash From Operations, 1 Yr. Growth % | 103.58 | 155.72 | -33.39 | 2.72 | 35.63 | |||||
Capital Expenditures, 1 Yr. Growth % | -26.06 | 7.85 | 64.02 | 39.06 | -0.33 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -299.93 | 385.69 | -66.7 | -151.26 | -344.86 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -581.79 | 300.6 | -63.13 | -130.28 | -476.28 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | 60 | 0 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -12.7 | 25.95 | 26.67 | 0.02 | 5.71 | |||||
Gross Profit, 2 Yr. CAGR % | -21.48 | 100.53 | 54.44 | -8.01 | 1.82 | |||||
EBITDA, 2 Yr. CAGR % | -20.9 | 115.95 | 55.9 | -10.67 | 1.4 | |||||
EBITA, 2 Yr. CAGR % | -26.41 | 218.08 | 77.91 | -14.26 | -0.2 | |||||
EBIT, 2 Yr. CAGR % | -28.22 | 265.43 | 84.48 | -14.12 | -0.5 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -45.47 | 428.61 | 127.55 | -16.38 | -0.9 | |||||
Net Income, 2 Yr. CAGR % | -52.02 | 324.46 | 140.62 | -34.49 | -26.2 | |||||
Normalized Net Income, 2 Yr. CAGR % | -37.04 | 810.94 | 107.57 | -29.83 | -23.56 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -52.14 | 313.02 | 141.44 | -33.56 | -26.25 | |||||
Accounts Receivable, 2 Yr. CAGR % | 3.73 | 25.55 | 22.38 | 1.74 | -34.23 | |||||
Inventory, 2 Yr. CAGR % | -7.02 | 5.08 | 15.35 | 16.08 | 14.64 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 3.18 | 1.28 | 4.6 | 7.85 | 8.65 | |||||
Total Assets, 2 Yr. CAGR % | -0.09 | 8.48 | 10.11 | 4.56 | 3.61 | |||||
Tangible Book Value, 2 Yr. CAGR % | 1.96 | 23.5 | 24.46 | 9.51 | 6.44 | |||||
Common Equity, 2 Yr. CAGR % | 1.9 | 22.62 | 23.65 | 9.27 | 6.31 | |||||
Cash From Operations, 2 Yr. CAGR % | -11.63 | 128.16 | 30.51 | -17.28 | 18.04 | |||||
Capital Expenditures, 2 Yr. CAGR % | -0.25 | -10.7 | 33 | 51.02 | 17.73 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -19.15 | 192.44 | 26.23 | -58.68 | 8.54 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -16.32 | 316.57 | 20.92 | -66.59 | 4.29 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | 36.93 | - | 26.49 | 0 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -4.7 | 7.04 | 16.51 | 17.2 | 3.67 | |||||
Gross Profit, 3 Yr. CAGR % | -12.89 | 15.99 | 53.42 | 31.36 | -2.63 | |||||
EBITDA, 3 Yr. CAGR % | -11.47 | 17.41 | 60.52 | 30.18 | -3.46 | |||||
EBITA, 3 Yr. CAGR % | -14.75 | 21.55 | 105.5 | 39.97 | -5.64 | |||||
EBIT, 3 Yr. CAGR % | -15.98 | 22.35 | 124.8 | 43.95 | -6.11 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -24.74 | 22.63 | 185.73 | 63.07 | -6.4 | |||||
Net Income, 3 Yr. CAGR % | -30.92 | 18.28 | 143.91 | 45.58 | -24.02 | |||||
Normalized Net Income, 3 Yr. CAGR % | -20.41 | 19.22 | 309.15 | 36.11 | -20.94 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -30.28 | 17.45 | 141.35 | 46.15 | -23.47 | |||||
Accounts Receivable, 3 Yr. CAGR % | -12.29 | 12.11 | 21.71 | 10.67 | -20.9 | |||||
Inventory, 3 Yr. CAGR % | -2.1 | -0.04 | 8.34 | 15.89 | 14.82 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 9.05 | 2.7 | 3.32 | 5.78 | 8.27 | |||||
Total Assets, 3 Yr. CAGR % | 4.15 | 4.39 | 7.78 | 7.6 | 4.53 | |||||
Tangible Book Value, 3 Yr. CAGR % | 8.41 | 13.01 | 19.39 | 18.52 | 8.13 | |||||
Common Equity, 3 Yr. CAGR % | 8.45 | 12.58 | 18.71 | 17.95 | 7.94 | |||||
Cash From Operations, 3 Yr. CAGR % | -13.53 | 25.93 | 51.36 | 20.5 | -2.46 | |||||
Capital Expenditures, 3 Yr. CAGR % | 11.62 | 2.38 | 9.36 | 34.99 | 31.49 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -24.05 | 41.14 | 42.2 | -6.52 | -27.16 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -21.4 | 36.59 | 86.2 | -23.79 | -26.54 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | 23.31 | 44.22 | - | 16.96 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -0.57 | 9.03 | 6.79 | 4.17 | 12.06 | |||||
Gross Profit, 5 Yr. CAGR % | 0.92 | 21.12 | 8.48 | 5.89 | 30.22 | |||||
EBITDA, 5 Yr. CAGR % | 0.89 | 22.59 | 9.74 | 5.43 | 33.45 | |||||
EBITA, 5 Yr. CAGR % | 56.88 | 48.33 | 12 | 5.94 | 53.75 | |||||
EBIT, 5 Yr. CAGR % | 107.26 | 53.69 | 12.4 | 6.43 | 62.06 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -41.08 | 6.96 | 17.16 | 5.22 | 87.07 | |||||
Net Income, 5 Yr. CAGR % | -45.3 | 0.72 | 13.8 | -6.61 | 51.21 | |||||
Normalized Net Income, 5 Yr. CAGR % | 13.61 | 105.78 | 12.21 | -3.93 | 109.37 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -48.5 | -0.41 | 14.58 | -6.49 | 50.21 | |||||
Accounts Receivable, 5 Yr. CAGR % | 6.7 | 0.74 | 0.21 | 7.84 | -4.85 | |||||
Inventory, 5 Yr. CAGR % | -0.91 | 4.31 | 4.54 | 6.12 | 10.82 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -0.94 | 5.43 | 7.25 | 4.73 | 5.42 | |||||
Total Assets, 5 Yr. CAGR % | -1.98 | 5.17 | 6.49 | 4.46 | 6.09 | |||||
Tangible Book Value, 5 Yr. CAGR % | 5.4 | 18.75 | 14.57 | 11.6 | 14.03 | |||||
Common Equity, 5 Yr. CAGR % | 5.38 | 18.23 | 14.29 | 11.24 | 13.59 | |||||
Cash From Operations, 5 Yr. CAGR % | -1.29 | 15.6 | 1.95 | 6.44 | 37.03 | |||||
Capital Expenditures, 5 Yr. CAGR % | -20.95 | -5.54 | 19.73 | 19.6 | 12.64 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -11 | 53.83 | -8.73 | -13.49 | 27.25 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -3.8 | 40.38 | -8.05 | -22.09 | 47.32 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | - | 24.57 | 24.57 |
- Stock Market
- Equities
- FCX Stock
- Financials Freeport-McMoRan Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition